|Day Low/High||44.63 / 47.10|
|52 Wk Low/High||38.00 / 72.96|
This is a market with opportunities for individuals who take the time to analyze companies, events and economic trends, Cramer said.
It was another busy week for the portfolio as we initiated two new positions and four holdings reported earnings.
Perspectives from Wall Street looks at how investors at any age can find opportunities in the health care sector.
Investors seem to be overreacting, but our initial thesis holds up.
We made a number of moves in the portfolio this week amid a flurry of earnings results and economic data.
It was a busy earnings week for the portfolio, with seven holdings reporting strong first-quarter results.
We made a variety of moves in the portfolio this week, including initiating a new position.
We initiated a new position this week and departed another, as the market rebounded from last week's sharp decline.
We initiated two new positions in the portfolio this week and exited two others, as the market couldn't keep last week's momentum.
We took some profits in two portfolio names this week as the Fed provided a catalyst for a market upsurge.
It's creating investment opportunities that just shouldn't exist, Cramer says.
It was a busy week for the portfolio as we added to several holdings, initiated a new position and exited several names.
We added to a pair of portfolio positions this week on weakness, as earnings reports remained strong and odds increased of an earlier Fed rate hike.
Cramer says that Honeywell is his one of his favorite industrial stocks and that the biotech sector is filled with strong buys, including Regeneron and Celgene.
Investors have to pay attention to see what's really worth buying.
We view the report as encouraging and reiterate our $60 price target.
Consider the tendency of options premiums to fall after an IPO, combined with the bullish view.
This week, we initiated a position in a healthcare name and exited a high tech portfolio holding, as the market moved slightly higher.
This new holding is No. 1 or 2 in nearly all of its markets.
The logic of owning the pure play is attractive.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.